Holy Basil

Ocimum tenuiflorum L. belongs to Lamiaceae, the mint family, alongside sweet basil, rosemary, and sage. NCBI Taxonomy files it as taxon 204149, with Ocimum sanctum as a synonym and holy basil as the common name; MSKCC lists both scientific names and stresses that holy basil should not be confused with culinary basil. Cohen (Journal of Ayurveda and Integrative Medicine 2014) describes an aromatic shrub thought to have originated in north central India that now grows throughout the tropics of the eastern world. Jamshidi and Cohen describe three types of tulsi. Rama or Sri tulsi, with green leaves, and Krishna or Shyama tulsi, with purplish leaves, are two cultivars of O. tenuiflorum. Vana, or wild forest tulsi, is a different species, Ocimum gratissimum, with about six times as much DNA, though it is traditionally used the same way. True tulsi types are distinguished from other basils by yellow pollen, high eugenol content, and a smaller chromosome number.

Genetics explains some of the visible differences. Upadhyay and colleagues (BMC Plant Biology 2015) published a draft genome of Krishna tulsi, assembling 374 megabases of an estimated 612-megabase genome. Genes for anthocyanin pigments were highly expressed in Krishna tulsi leaves, accounting for their purple colour, while genes for ursolic acid production were most active in young leaves of the Rama type; mass spectrometry confirmed eugenol and ursolic acid in the plant. Cohen notes that Krishna tulsi has a higher phenolic content and antioxidant capacity than Vana tulsi. The leaf, fresh or dried, is the part most often used.

MSKCC attributes holy basil’s effects to constituents including eugenol, carvacrol, ursolic acid (PubChem CID 64945), β-caryophyllene, the flavonoids orientin and vicenin, and rosmarinic acid. Eugenol (PubChem CID 3314, C10H12O2) gives tulsi its clove-like smell, and Jamshidi and Cohen describe it as the major bioactive compound common to all three tulsi types, though amounts vary between cultivars and with growing conditions. The Merck Manual adds camphor, eucalyptol, and bisabolenes. Quality is a practical issue: Cohen cites reports that European products sold as tulsi were frequently substituted with sweet basil (Ocimum basilicum), and that tulsi leaves grown in polluted areas carried almost twice the concentration of toxic elements as leaves from clean areas. A capsule labelled holy basil may not contain what the trials tested.

Jamshidi and Cohen (Evidence-Based Complementary and Alternative Medicine 2017) note that tulsi, Tulasi in Sanskrit, has been used in Ayurvedic medicine for more than 3,000 years. Cohen records its traditional titles, The Incomparable One, Mother Medicine of Nature, and The Queen of Herbs, and its Ayurvedic description as hot and bitter in taste, able to penetrate deep tissues and balance the kapha and vata doshas. Daily use was said to prevent disease and promote longevity. Traditional indications were broad: anxiety, cough, asthma, diarrhoea, fever, dysentery, arthritis, eye diseases, earache, indigestion, vomiting, skin diseases, snake and scorpion bites, and malaria. The Indian Materia Medica describes leaf extracts for bronchitis, rheumatism, and fever, leaf juice dropped into the ear for earache, and tulsi tea for stomach and liver complaints.

Tulsi is as much a sacred plant as a medicine. Cohen explains that in Hinduism tulsi is worshipped as a goddess, every part of the plant is considered holy, and a Hindu household is considered incomplete without a tulsi plant, typically grown in an ornate earthen pot in the courtyard. Its clove-like aroma, from eugenol, was also valued for repelling mosquitoes and flies. The leaves are taken in morning and evening rituals, steeped as tea, and used to make holy water, a practice Cohen notes in some Greek Orthodox churches as well. Beads carved from tulsi wood or seeds are strung into malas for prayer and meditation. Hundreds of thousands of tulsi plants have been planted around the Taj Mahal in an effort to protect the marble from air pollution.

Laboratory research came later. Jamshidi and Cohen note animal studies over the past fifty years reporting effects on blood glucose and lipids, and laboratory work has attributed an enormous list of actions to tulsi; Cohen’s list includes anti-stress, antidiabetic, and anti-inflammatory effects, but also antithyroid, antifertility, and anticoagulant activity, a reminder that strong pharmacology cuts both ways. Small human trials followed in India, including a crossover trial in type 2 diabetes published in 1996. Standardized commercial extracts were then tested against placebo for stress, in India in 2012 and in Australia in 2022. Tulsi teas are now sold worldwide. Readers should know that the author of both major reviews cited here declared paid consultancy for a company that sells tulsi products.

Stress hormones are the main proposed target. MSKCC summarizes laboratory and animal work suggesting that holy basil inhibits cortisol release, blocks the corticotropin-releasing hormone receptor CRHR1, and inhibits the enzymes 11β-hydroxysteroid dehydrogenase type 1 and catechol-O-methyltransferase, which regenerate cortisol and break down catecholamines respectively. In the one rigorous human trial to measure this, Lopresti and colleagues (Frontiers in Nutrition 2022) found lower hair cortisol after eight weeks of extract, and smaller rises in salivary cortisol, salivary amylase, and blood pressure during a laboratory stress test, consistent with damping of the hypothalamic-pituitary-adrenal axis and sympathetic nervous system. That is a single, industry-funded trial of one proprietary extract.

For blood sugar, MSKCC cites laboratory evidence that holy basil leaf extracts stimulate insulin secretion from pancreatic tissue and beta cells. Jamshidi and Cohen add that eugenol may lower glucose by competing with glucose for binding to serum albumin and by slowing the conversion of complex carbohydrates to glucose. Cohen attributes anti-inflammatory effects seen in animal models to eugenol and linoleic acid, acting through inhibition of the cyclooxygenase and lipoxygenase pathways, the same broad targets as anti-inflammatory painkillers. These mechanisms are plausible but come mainly from cell and animal studies at doses well above typical human intake.

Some actions matter more for safety than benefit. Panda and Kar (Pharmacological Research 1998) gave male mice 0.5 g of leaf extract per kilogram daily for 15 days and found lower serum thyroxine (T4) without a change in T3. Ahmed and colleagues (Journal of Basic and Clinical Physiology and Pharmacology 2002) found that a leaf extract given to rats for 48 days reduced sperm count and motility, an effect they attributed to anti-androgenic activity and that reversed two weeks after stopping. The Merck Manual notes that holy basil appears to inhibit platelet aggregation and prolong clotting times. Cohen cites laboratory evidence that tulsi increases the activity of liver cytochrome P450 enzymes, which could in principle change drug levels; no human interaction studies were found.

Stress is the best-studied use. Saxena and colleagues (Evidence-Based Complementary and Alternative Medicine 2012) randomized 150 adults with symptoms of general stress to an extract called OciBest, 1,200 mg of actives per day, or placebo for six weeks. Forgetfulness, exhaustion, recent sleep problems, and recent sexual problems improved more on the extract, and total symptom scores improved about 39% more than with placebo; no adverse events were reported. Lopresti and colleagues (Frontiers in Nutrition 2022) randomized 100 stressed adults aged 18 to 65 to 125 mg of a standardized extract (Holixer) twice daily or placebo for eight weeks. Perceived stress fell 37% versus 19%, and insomnia scores 48% versus 27%, with lower hair cortisol at eight weeks. Sleep measured by a wrist tracker did not differ between groups, and the study was funded by the extract’s manufacturer.

Anxiety and thinking have smaller evidence bases. Bhattacharyya and colleagues (Nepal Medical College Journal 2008) gave 35 adults with generalized anxiety disorder 500 mg of leaf extract twice daily after meals for 60 days and reported reduced anxiety, stress, and depression scores; Lopresti’s team notes that this study had no placebo group, so it cannot separate the herb from time and expectation. Sampath and colleagues (Indian Journal of Physiology and Pharmacology 2015) gave healthy adults 300 mg of ethanolic leaf extract or placebo daily for 30 days and found faster reaction times and fewer errors on memory and attention tasks with the extract. Both are small single-centre studies that have not been independently replicated.

Blood sugar and metabolic health make up most of the human literature. Agrawal, Rai, and Singh (International Journal of Clinical Pharmacology and Therapeutics 1996) ran a single-blind crossover trial of holy basil leaves versus placebo leaves in type 2 diabetes; the Merck Manual describes it as involving 40 patients. Fasting glucose fell by 21 mg/dL (17.6%) and after-meal glucose by 15.8 mg/dL (7.3%) during the basil period. The Merck Manual also cites a 90-day study of 60 patients in which adding holy basil to glibenclamide gave slightly more improvement in glucose and HbA1c than the drug alone. Jamshidi and Cohen counted 15 metabolic studies, but most were small, short, unblinded, or poorly reported. Holy basil is not a substitute for diabetes treatment, and any glucose-lowering effect is a reason for monitoring, not for adjusting medicines on your own.

Other uses are early. Mondal and colleagues (Journal of Ethnopharmacology 2011) gave 300 mg of ethanolic leaf extract or placebo to 24 healthy volunteers in a crossover trial and found increases in interferon-gamma, interleukin-4, T-helper cells, and natural killer cells after four weeks; laboratory markers like these do not show fewer or milder infections. MSKCC notes small studies of tulsi mouthwashes for oral health and of a multi-herb eye drop formulation, and Cohen reports trials in which tulsi mouth rinses reduced levels of Streptococcus mutans, the main tooth-decay bacterium, comparably to 0.2% chlorhexidine. Jamshidi and Cohen conclude that there is insufficient evidence for any specific tulsi formulation in any one condition, and that larger, longer, standardized trials are needed before specific recommendations can be made.

There is no official dose. Holy basil has no EU herbal monograph and no NCCIH fact sheet, so doses come from individual trials of specific products: 1,200 mg per day of the OciBest extract for six weeks; 125 mg of the Holixer extract twice daily for eight weeks; 500 mg of leaf extract twice daily after meals for 60 days in anxiety; 300 mg of ethanolic leaf extract daily for 30 days in the cognition study and four weeks in the immunity study; and 250 mg of extract twice daily before meals for eight weeks in a small obesity study. Across 24 studies, Jamshidi and Cohen found doses from 300 mg to 3,000 mg per day of aqueous leaf extract and 300–1,000 mg once or twice daily of ethanolic extract, for 2 to 13 weeks. These products are not interchangeable.

Tea is the traditional form. Cohen notes that many Ayurvedic practitioners recommend regular tulsi tea as a daily lifestyle practice, and dried leaf teas, alone or blended, are widely sold. No trial has established a tea dose or tested tea against placebo for a clinical outcome, so tea should be thought of as a food-level exposure rather than a treatment. The Merck Manual says holy basil seems safe for most people when taken by mouth for up to eight weeks and that the safety of longer use has not been studied; the longest study in the Jamshidi review lasted 13 weeks.

Product choice matters because substitution and contamination have been reported. Look for a product that names Ocimum tenuiflorum or Ocimum sanctum, the plant part, the type of extract and its standardization, and independent testing for identity, heavy metals, and pesticides. The trial extracts were proprietary; Holixer, for example, was standardized to at least 5% of a manufacturer-defined bioactive complex, so results from one brand do not transfer to another. The clinical studies used leaves, teas, tinctures, and extracts, not essential oil, which is a concentrated product and not a studied oral remedy. Stop and seek advice if new symptoms appear.